BDP have been praised in Addiction Journal’s August 2018 edition for our work supporting a research project exploring the impact of buprenorphine and methadone on the reduction of mortality rates.

People with opioid dependence have more than 10 times the risk of premature mortality than the general population.

First published earlier in 2018, The Impact of Buprenorphine and Methadone on Mortality has been led by long-term BDP partner Professor Matthew Hickman from the University of Bristol’s Population Health Sciences at Bristol Medical School.

Focused on primacy care settings across the UK, the project aimed to estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is associated with a greater reduction in the risk of mortality.

We are grateful for comments and contributions from patients and drug workers at Bristol Drugs Project (BDP)… in particular Rachel Ayres and Louisa Chowen at BDP for organizing patient and public involvement.

BDP contributed to the research project by providing access to our experienced staff and service users as part of our work delivering OST alongside GP’s in 42 surgeries across Bristol.

Read the article

The research was co-written by King’s College London and The University of Manchester with support from NIHR Health Services and Delivery Research and Blackpool’s Horizon Drug and Alcohol Service. Additional support came from NIHR Health Protection Research Unit in Evaluation of Interventions  and the NIHR School of Public Health Research.